4.7 Review

Developmental programming of cardiovascular function: a translational perspective

Journal

CLINICAL SCIENCE
Volume 134, Issue 22, Pages 3023-3046

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/CS20191210

Keywords

-

Funding

  1. Canadian Institutes of Health Research [MOP 142396, FS154313]
  2. Women and Children's Health Research Institute (WCHRI) through the Stollery Children's Hospital Foundation
  3. Lois Hole Hospital for Women
  4. Canada Research Chair in Developmental and Integrative Pharmacology
  5. Canada Research Chair in Maternal and Perinatal Cardiovascular Health
  6. Distinguished University Professorship at the University of Alberta

Ask authors/readers for more resources

The developmental origins of health and disease (DOHaD) is a concept linking pre- and early postnatal exposures to environmental influences with long-term health outcomes and susceptibility to disease. It has provided a new perspective on the etiology and evolution of chronic disease risk, and as such is a classic example of a paradigm shift. What first emerged as the 'fetal origins of disease', the evolution of the DOHaD conceptual framework is a storied one in which preclinical studies played an important role. With its potential clinical applications of DOHaD, there is increasing desire to leverage this growing body of preclinical work to improve health outcomes in populations all over the world. In this review, we provide a perspective on the values and limitations of preclinical research, and the challenges that impede its translation. The review focuses largely on the developmental programming of cardiovascular function and begins with a brief discussion on the emergence of the 'Barker hypothesis', and its subsequent evolution into the more-encompassing DOHaD framework. We then discuss some fundamental pathophysiological processes by which developmental programming may occur, and attempt to define these as 'instigator' and 'effector' mechanisms, according to their role in early adversity. We conclude with a brief discussion of some notable challenges that hinder the translation of this preclinical work.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available